Duration: CME/CE Points: Author(s):
Contact Hours : 1

GENERAL THORACIC SURGERY: Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer is organized by The Society of Thoracic Surgeons (STS).

Release Date: Oct 01, 2018
Expiry Date: Oct 01, 2020

Accreditation: 1.0 AMA PRA Category 1 Credit ™

Each STS CME activity in The Annals consists of a self-study test on an original article from one of the journal's major subject categories (Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Cardiothoracic Anesthesiology), a statement of the learning objectives and an evaluation of the activity.

Learning Objective:
After reading this article, the learner should be able to:
• describe the rate of unsuspected microscopic N2 disease at the time of surgical resection for non-small cell lung cancer (NSCLC).
• identify the current national guideline recommendations for the management of microscopic N2 disease.
• recognize the controversies in the results of meta-analyses and randomized control trials in the management of N2 disease.
• indicate the expected outcomes from the use of adjuvant therapy, chemotherapy alone and chemoradiotherapy.

Target Audience

The intended audience consists of thoracic and cardiothoracic surgeons, pediatric cardiac surgeons, general surgeons, anesthesiologists, oncologists, cardiologists, pulmonologists, and radiologists. MDs and DOs can take the CME activities for credit; non-MDs and non-DOs should not claim credit.


Activity Fee : Fee Details will be updated soon


Thoracic Surgery

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.